社会脆弱性指数与头颈癌患者拒绝推荐手术治疗的相关性
该回顾性队列分析基于2000至2020年SEER数据库中83,184例头颈鳞状细胞癌(HNSCC)病例,按居住县的社会脆弱性指数(SVI)四分位分组。2.6%(2,165例)患者拒绝医生推荐的手术治疗;较高的SVI、男性、高龄、更晚期疾病、非西班牙裔黑人或夏威夷原住民/亚太岛民种族及单身状态与更高的拒绝手术可能性相关。结论认为SVI是HNSCC患者拒绝推荐手术治疗的重要因素,晚期疾病与社会脆弱性似乎相互作用影响治疗决策。
要点
- 83,184例HNSCC患者中2.6%(2,165例)拒绝医生推荐的手术治疗。
- 较高的SVI、男性、高龄、更晚期疾病、非西班牙裔黑人或夏威夷原住民/亚太岛民种族及单身状态与更高拒绝手术可能性相关。
- SVI是HNSCC患者拒绝推荐手术治疗的重要因素,晚期疾病与社会脆弱性似乎相互作用影响治疗决策。
核心结论
- SVI是HNSCC患者拒绝推荐手术治疗的重要因素。
- 晚期疾病阶段与社会脆弱性似乎相互作用,影响治疗决策。
- 作者认为,文化胜任的照护和对社会脆弱患者的支持可能减轻治疗接受方面的差异,并可能改善生存结局。
研究设计与样本
- 回顾性队列分析,基于2000至2020年最新可用的SEER数据库中记录的HNSCC病例。
- 收集包括居住县在内的各种人口学及疾病相关变量,按患者居住县分配CDC社会脆弱性指数(SVI)并分为四个SVI四分位组。
- 采用Pearson卡方检验和二项逻辑回归分析变量对患者拒绝手术治疗的影响。
主要发现
- 在83,184例患者中,2.6%(2,165例)拒绝了医生推荐的手术治疗。
- 较高的社会脆弱性(较高SVI)、男性、高龄、更晚期疾病阶段、非西班牙裔黑人或夏威夷原住民/亚太岛民种族和族裔、以及单身婚姻状态与更高的拒绝手术可能性相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of county-level social vulnerability on patients' decision to refuse recommended surgical treatment. METHODS: Retrospective cohort analysis conducted on HNSCC cases documented in the latest available SEER databases from 2000 to 2020; various demographic, including county of residence, and disease-related variables were collected. CDC's Social Vulnerability Index (SVI) was assigned based on patients' county of residence, and patients were subsequently categorized into four SVI quartiles. Pearson chi-square tests and binomial logistic regression was conducted to determine the impact of variables on patients' refusal of surgical treatment. RESULTS: Among 83,184 patients, 2.6% (2,165) refused surgical intervention recommended by their physician as part of treatment. Social vulnerability (higher SVI), male sex, older age, more advanced disease stage, belonging to non-Hispanic Black or Native Hawaiian/Asian Pacific Islander Race and Origin, and single marital status were associated with higher likelihood of refusing surgery. CONCLUSION: SVI is a significant factor in the refusal of recommended surgical treatment in HNSCC patients. Advanced disease stages and social vulnerability appear to interplay, influencing treatment decisions. Culturally competent care and support for socially vulnerable patients may mitigate disparities in treatment acceptance, potentially improving survival outcomes. LEVEL OF EVIDENCE: 3 Laryngoscope, 135:2062-2069, 2025.
引用
- Ershadifar S, Mo JT, Colback AA, et al. Association of Social Vulnerability Index With Declining Recommended Surgical Treatment in Head and Neck Cancer Patients. Laryngoscope. 2025. PMID: 39777427. doi:10.1002/lary.31999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。